Surgical management of bladder carcinoma

Cancer Control

Volumn 9, Issue 4, 2002, Pages 284-292

  Carrion, Rafael ^a   Seigne, John ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER BIOPSY; BLADDER CARCINOMA; BLADDER RECONSTRUCTION; CANCER DIAGNOSIS; CANCER STAGING; CYSTECTOMY; CYSTOSCOPY; ENDOSCOPIC SURGERY; HUMAN; LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSTATE BIOPSY; QUALITY OF LIFE; REOPERATION; REVIEW; SURGICAL TECHNIQUE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URETHRA SURGERY;

EID: 0036638976     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480200900403     Document Type: Review

References (55)

1. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
2. Should pT1 transitional cell cancers of the bladder still be classified as superficial?
3. Surveillance of stage 0, grade I bladder, cancer by cytology alone: Is it acceptable?
4. Evaluation and management of patients with superficial bladder cancer
5. Selecting initial therapy for bladder cancer
6. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of follow up
7. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer
8. The natural history of a T1 bladder cancer: Life-long tumour diathesis
9. Indications for urethrectomy
10. Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC
11. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
12. Contemporary management of stage T1 transitional cell carcinoma of the bladder
13. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome
14. Electrovaporization of the prostate with the Gyrus device
15. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid
16. Fluorescence detection of bladder carcinoma
17. Ta and T1 bladder cancer: Location, recurrence and progression
18. Superficial bladder cancer: Progression and recurrence
19. Superficial bladder tumors (stage pTa, grades 1 and 2): The importance of recurrence pattern following initial resection
20. Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer
21. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: Progression-free and disease specific survival with minimum 10-year followup
22. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome
23. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer
24. Partial cystectomy for invasive bladder cancer
25. Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) performed completely intracorporeally: The initial 5 cases
26. Their initial experience with laparoscopy-assisted cystectomy
27. Laparoscopic assisted cystectomy and lymphadenectomy for bladder cancer: Initial experience
28. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
29. Management of invasive bladder cancer: A meticulous pelvic node dissection can make a difference
30. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer
31. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens
32. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy
33. Management of the patient with bladder cancer. Urethral recurrence
34. Urethral recurrence in patients with orthotopic ileal neobladders
35. Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?
36. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: Results of a contemporary cystectomy series from M.D. Anderson Cancer Center
37. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: A pathological review of female cystectomy specimens
38. The Hautmann neobladder with a chimney: A versatile modification
39. Ileal orthotopic bladder substitutes. What we have learned from 12 years' experience with 200 patients
40. Ureteral carcinoma in situ at radical cystectomy: Does the margin matter?
41. Ureteral frozen section analysis during cystectomy: A reassessment
42. Urinary Diversion and Reconstruction
43. Choosing a Continent Urinary Diversion
44. Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer
45. Summary of complications of ureteroileal conduit with radical cystectomy: Review of 336 cases (by Jerry W Sullivan, MD, Harry Grabstald, MD, and Willet F. Whitmore, Jr)
46. Estimated blood loss and transfusion requirements of radical cystectomy
47. Analysis of early complications after radical cystectomy: Results of a collaborative care pathway
48. Routine postoperative intensive care monitoring is not necessary after radical cystectomy
49. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting
50. Cystectomy for bladder cancer: A contemporary series
51. Retrospective review and long-term follow-up of radical cystectomy in a developing country
52. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
53. Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion [Polish]
54. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation
55. Predicting the survival of bladder carcinoma patients treated with radical cystectomy